![]() |
市場調查報告書
商品編碼
1871084
重組蛋白食品配料市場機會、成長促進因素、產業趨勢分析及預測(2025-2034年)Recombinant Protein Food Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球重組蛋白食品配料市場價值為 9 億美元,預計到 2034 年將以 7.8% 的複合年成長率成長至 19 億美元。

隨著生物技術的進步和消費者對永續和功能性食品日益成長的需求重塑食品創新格局,該行業正迅速擴張。慢性病發病率的上升和對個人化營養的日益重視是推動市場需求的關鍵因素。製造商正在提升合成生物學、菌株工程和精準發酵的能力,以開發能夠複煞車物源蛋白的質地、營養成分和感官特性的蛋白質。這項進展使得大規模生產成為可能,重組蛋白從實驗室概念轉變為乳製品、肉類和飲料等應用領域的商業配料。永續性已成為這一發展進程的核心,生產商正致力於循環和低碳生產過程。諸如氣體發酵和農業副產品利用等新技術正在降低碳排放強度,並有可能實現碳負排放蛋白的生產。這些永續發展措施符合全球脫碳和ESG目標,吸引了優先考慮環境責任的投資者。對環保生產方式的日益重視也增強了消費者的信任,並有助於獲得全球監管機構的批准。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 9億美元 |
| 預測值 | 19億美元 |
| 複合年成長率 | 7.8% |
預計到2024年,精準發酵技術將佔70%的市場。此技術利用基因工程改造的微生物生產高純度、高穩定性的蛋白質,這些蛋白質與動物性蛋白質高度相似。由於其可擴展性、合規性和成本效益,精準發酵已成為行業標準,並支持乳製品、雞蛋和肉類替代品的大規模生產。
2024年,結構蛋白市佔率佔40%,預計到2034年將達到7.78億美元。這些蛋白質在食品配方中發揮著至關重要的作用,尤其是在植物肉、起司和烘焙食品等領域,它們賦予食物結構、穩定性和結合力。產業合作加速了生產進程,使得各種替代食品領域所需的關鍵蛋白質成分能夠大規模生產。
2024年北美重組蛋白食品配料市場規模為3.79億美元,預計2034年將以8%的複合年成長率成長。該地區受益於強大的生物技術生態系統、美國食品藥物管理局(FDA)在GRAS框架下提供的有利監管路徑、不斷成長的風險投資以及消費者對永續蛋白替代品日益增強的認知。此外,合作計畫和資助計畫也持續推動北美地區重組蛋白配料的生產和商業化。
全球重組蛋白食品配料市場的主要參與者包括帝斯曼-菲美意(DSM-Firmenich)、Geltor Inc.、Perfect Day Inc.、EVERY Company、Kerry Group plc、奇華頓(Givaudan SA)、Motif FoodWorks Inc.、諾維信(Novozymes A/S)、科漢森控股(Ihr)、A.a. Hansen(Novozymes A/S)、科漢森控股(I.3.H Foods)。這些公司正採取策略措施擴大市場佔有率並提升競爭力。各公司大力投資研發,以最佳化蛋白質設計、提高生產效率,並透過精準發酵實現更好的規模化生產。與食品製造商和生技公司進行策略合作、建立夥伴關係和成立合資企業,有助於加速新型蛋白質的商業化進程。此外,各公司也正在擴大全球生產能力,並進軍新的區域市場,以滿足不斷成長的需求。
The Global Recombinant Protein Food Ingredients Market was valued at USD 900 million in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 1.9 Billion by 2034.

The industry is expanding rapidly as advancements in biotechnology and the growing consumer preference for sustainable and functional foods reshape the food innovation landscape. Rising incidences of chronic illnesses and the growing emphasis on personalized nutrition are key drivers fueling market demand. Manufacturers are enhancing the capabilities of synthetic biology, strain engineering, and precision fermentation to develop proteins that replicate the texture, nutritional profile, and sensory characteristics of animal-derived proteins. This progress is enabling large-scale production, transforming recombinant proteins from laboratory concepts to commercial ingredients in dairy, meat, and beverage applications. Sustainability has become central to this evolution, with producers focusing on circular and low-carbon manufacturing processes. Novel technologies such as gas fermentation and the use of agricultural byproducts are reducing carbon intensity, potentially leading to carbon-negative protein production. These sustainable developments align with global decarbonization and ESG goals, attracting investors who prioritize environmental responsibility. The growing emphasis on eco-friendly production methods also strengthens consumer trust and global regulatory approval.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $900 Million |
| Forecast Value | $1.9 Billion |
| CAGR | 7.8% |
The precision fermentation segment held a 70% share in 2024, as this method utilizes engineered microorganisms to produce highly pure and consistent proteins that closely resemble animal proteins. This approach has become the industry standard due to its scalability, regulatory compliance, and cost-efficiency, supporting mass production for dairy, egg, and meat substitute applications.
The structural proteins segment held a 40% share in 2024 and is projected to reach USD 778 million by 2034. These proteins play a crucial role in providing structure, stability, and binding properties in food formulations, particularly within plant-based meat, cheese, and bakery applications. Industrial partnerships have accelerated the production process, enabling large-scale manufacturing of key protein ingredients used across alternative food segments.
North America Recombinant Protein Food Ingredients Market was valued at USD 379 million in 2024 and is expected to grow at a CAGR of 8% through 2034. The region benefits from a robust biotechnology ecosystem, favorable FDA regulatory pathways under the GRAS framework, increasing venture capital investments, and rising consumer awareness of sustainable protein alternatives. Additionally, collaborative initiatives and funding programs continue to strengthen the production and commercialization of recombinant protein ingredients across North America.
Leading companies in the Global Recombinant Protein Food Ingredients Market include DSM-Firmenich, Geltor Inc., Perfect Day Inc., The EVERY Company, Kerry Group plc, Givaudan SA, Motif FoodWorks Inc., Novozymes A/S, Chr. Hansen Holding A/S and Impossible Foods Inc. are Major players in the Recombinant Protein Food Ingredients Market and are employing strategic measures to expand their market presence and enhance competitiveness. Companies are heavily investing in research and development to optimize protein design, improve production efficiency, and achieve better scalability through precision fermentation. Strategic collaborations, partnerships, and joint ventures with food manufacturers and biotechnology firms are helping accelerate the commercialization of novel proteins. Firms are also expanding their global manufacturing capacities and entering new regional markets to meet rising demand.